SlideShare a Scribd company logo

Case Study: Dementia

ClinActis Pte Ltd is a full service CRO providing clinical trial services to the pharmaceutical, medical device, medical nutrition and biotech companies in Asia Pacific. Established in 2009, ClinActis Pte Ltd is headquartered in Singapore. ClinActis Experience • 33 years experience in clinical research in pharmaceutical and biotechnology companies as well as CROs • 27 years experience in Asia Pacific, including Australia/New Zealand, China, Malaysia, Hong Kong, India, Indonesia, The Philippines, Singapore, South Korea, Taiwan, Thailand and Japan • Extensive knowledge of regulatory frameworks, best KOLs and sites across the region • Vast therapeutic experience including Cardiovascular, CNS, Endocrinology, Infectious diseases, Oncology, and Respiratory

1 of 23
Download to read offline
ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902
Telephone: +65 6436 5500 - info@clinactis.com
Case Study:
Dementia CNS
ClinActis is exclusively focused on Asia Pacific, with solid expertise in applying international quality
standards to regional specificities. ClinActis is flexible in our approach to work scope and budgeting and
contracting process.
Delivering Quality to Our Clients
ClinActis is committed to implementing international standards in clinical trials. Our ability to deliver high
quality results to our clients is based on recruiting and maintaining the best talent within our
organization. ClinActis’ senior management is fully accountable for the quality of deliverables to our
clients.
ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902
Telephone: +65 6436 5500 - info@clinactis.com
Your Proactive Clinical Research Partner in Asia Pacific
	
  	
  
ClinActis Pte Ltd is a full service CRO
providing clinical trial services to the
pharmaceutical, medical device, medical
nutrition and biotech companies in Asia
Pacific. Established in 2009, ClinActis Pte Ltd
is headquartered in Singapore.
ClinActis Value Proposition
ClinActis is a multicultural company. As such,
the team is able to communicate effectively
with international clients.
ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902
Telephone: +65 6436 5500 - info@clinactis.com
Mission and Vision
	
  	
   With headquarters based in Asia, all corporate
decisions are made within the region, in order to
better anticipate our client needs and adapt to local
specificities.
Vision
Our vision is to become the reference CRO
specialized in conducting clinical research in Asia
Pacific, offering state of the art quality services, with
cost effective solutions.
We strive to employ people with genuine expertise
in the region and with a passion for excellence, to
work with our clients in the most pro-active way, and
to build a relationship based on trust, transparency
and strong ethics.
Mission
Our mission is to provide our clients with unique
and dynamic expertise in applying global drug
development standards to the specificities of
each country in the Asia Pacific region.
Christophe Tournerie, MD – Owner and CEO
Dr. Tournerie has more than 20 years experience in clinical research in Europe
and Asia Pacific including Japan, working with biotechnology companies,
pharmaceutical companies and clinical research organizations.
After completion of his medical studies in Paris and various hospital
assignments in France, Dr. Tournerie spent a period of 3 years at the National
Medical Research Institute in France in the field of drug development in anti-HIV
products.
ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902
Telephone: +65 6436 5500 - info@clinactis.com
About Our Founder
His introduction to the pharmaceutical industry was as Medical Director in an American biotechnology
company developing anti-HIV products. Then, he moved to a large global CRO, heading the Project
management Department for South Europe, and then as Head of Operations in the Japan affiliate.
Later, Dr. Tournerie headed the Asian clinical research activity for a multi-national Pharmaceutical
Company, based in Singapore.
More recently, Dr. Tournerie was Vice President Asia Pacific for a large global CRO, based in
Singapore. During this assignment, Dr. Tournerie developed the business strategy for the region,
successfully established and directed operations in 12 countries and built a highly professional team.
ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902
Telephone: +65 6436 5500 - info@clinactis.com
Operational Expertise – Regional Footprint
ClinActis Experience
§  33 years experience in clinical
research in pharmaceutical and
biotechnology companies as well as
CROs
§  27 years experience in Asia Pacific,
including Australia/New Zealand,
China, Malaysia, Hong Kong, India,
Indonesia, the Philippines,
Singapore, South Korea, Taiwan,
Thailand, Japan and Vietnam
§  Extensive knowledge of regulatory
frameworks, best KOLs and sites
across the region
§  Vast therapeutic experience including
Oncology, Infectious diseases, CNS,
Cardiovascular, Endocrinology, and
Respiratory
ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902
Telephone: +65 6436 5500 - info@clinactis.com
Alzheimer’s Disease Clinical Trial Considerations in Asia Pacific
§  The total population of the Asia Pacific region in 2015 was estimated from
United Nations data at 4.4 billion. The population aged 60 years and above
was estimated at 12% in 2015.
§  The dementias are a group of diseases characterised by loss of short-term
memory, other thinking (cognitive) abilities and daily functioning.
§  Alzheimer’s disease and vascular dementia are the most common types of
dementia.
§  The number of those with dementia was forecasted to increase in the Asia
Pacific region from 13.7 million people in 2005 to 64.6 million by 2050.
Ad

Recommended

ClinActis: Logistics of Asian Based Clinical Trials
ClinActis: Logistics of Asian Based Clinical TrialsClinActis: Logistics of Asian Based Clinical Trials
ClinActis: Logistics of Asian Based Clinical TrialsClinActis Pte Ltd
 
ClinActis - Case Study: Global Colorectal Oncology
ClinActis - Case Study: Global Colorectal OncologyClinActis - Case Study: Global Colorectal Oncology
ClinActis - Case Study: Global Colorectal OncologyClinActis Pte Ltd
 
Market Analysis of Clinical Research in Asia Pacific
Market Analysis of Clinical Research in Asia PacificMarket Analysis of Clinical Research in Asia Pacific
Market Analysis of Clinical Research in Asia PacificClinActis Pte Ltd
 
ClinActis - Chinese E5 Bridging Study
ClinActis - Chinese E5 Bridging StudyClinActis - Chinese E5 Bridging Study
ClinActis - Chinese E5 Bridging StudyClinActis Pte Ltd
 

More Related Content

What's hot

ClinActis SOPs and Regional Project Management
ClinActis SOPs and Regional Project ManagementClinActis SOPs and Regional Project Management
ClinActis SOPs and Regional Project ManagementClinActis Pte Ltd
 
Fakhry & Dr Ahmed Algarzaie Hospital
Fakhry & Dr Ahmed Algarzaie HospitalFakhry & Dr Ahmed Algarzaie Hospital
Fakhry & Dr Ahmed Algarzaie HospitalAbbas Ahmed
 
Nova Specialty Hospital - Forerunners Healthcare Tourism
Nova Specialty Hospital - Forerunners Healthcare TourismNova Specialty Hospital - Forerunners Healthcare Tourism
Nova Specialty Hospital - Forerunners Healthcare Tourismanan adisa
 
KPSCS CORPORATE PRESENTATION
KPSCS CORPORATE PRESENTATIONKPSCS CORPORATE PRESENTATION
KPSCS CORPORATE PRESENTATIONAnkit Tyagi
 
Toi article narayana hrudayala
Toi article narayana hrudayalaToi article narayana hrudayala
Toi article narayana hrudayalaRathan Kamble
 
UTS and SeerPharma - partners in Good Manufacturing Practice (GMP) education
UTS and SeerPharma - partners in Good Manufacturing Practice (GMP) educationUTS and SeerPharma - partners in Good Manufacturing Practice (GMP) education
UTS and SeerPharma - partners in Good Manufacturing Practice (GMP) educationutspharmacy
 
Kuantum Cro St V021
Kuantum Cro St V021Kuantum Cro St V021
Kuantum Cro St V021serhan
 
Nordion corporate presentation_2014_q1
Nordion corporate presentation_2014_q1Nordion corporate presentation_2014_q1
Nordion corporate presentation_2014_q1nordion1
 
What are the benefits of QMS for a fertility centre and how do we measure them
What are the benefits of QMS for a fertility centre and how do we measure themWhat are the benefits of QMS for a fertility centre and how do we measure them
What are the benefits of QMS for a fertility centre and how do we measure themSandro Esteves
 
Yasser Jasser CV 2016
Yasser Jasser CV 2016Yasser Jasser CV 2016
Yasser Jasser CV 2016Yasser Jasser
 
Activa Cro Presentacion Jan 09
Activa Cro Presentacion Jan 09Activa Cro Presentacion Jan 09
Activa Cro Presentacion Jan 09marcetotah
 
CV LB v8 short 2015 Document
CV LB v8 short 2015 DocumentCV LB v8 short 2015 Document
CV LB v8 short 2015 DocumentLesley Bloom
 
Nordion corporate presentation
Nordion corporate presentationNordion corporate presentation
Nordion corporate presentationnordion1
 
Joint Commission International (JCI)
Joint Commission International (JCI)Joint Commission International (JCI)
Joint Commission International (JCI)RadhaDeosthalee
 
IDSC Expertise Capabilities Services
IDSC Expertise Capabilities ServicesIDSC Expertise Capabilities Services
IDSC Expertise Capabilities ServicesMark Creswell
 

What's hot (18)

ClinActis SOPs and Regional Project Management
ClinActis SOPs and Regional Project ManagementClinActis SOPs and Regional Project Management
ClinActis SOPs and Regional Project Management
 
The role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in IrelandThe role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in Ireland
 
Fakhry & Dr Ahmed Algarzaie Hospital
Fakhry & Dr Ahmed Algarzaie HospitalFakhry & Dr Ahmed Algarzaie Hospital
Fakhry & Dr Ahmed Algarzaie Hospital
 
Nova Specialty Hospital - Forerunners Healthcare Tourism
Nova Specialty Hospital - Forerunners Healthcare TourismNova Specialty Hospital - Forerunners Healthcare Tourism
Nova Specialty Hospital - Forerunners Healthcare Tourism
 
ppt good clinical practice
ppt good clinical practiceppt good clinical practice
ppt good clinical practice
 
KPSCS CORPORATE PRESENTATION
KPSCS CORPORATE PRESENTATIONKPSCS CORPORATE PRESENTATION
KPSCS CORPORATE PRESENTATION
 
Toi article narayana hrudayala
Toi article narayana hrudayalaToi article narayana hrudayala
Toi article narayana hrudayala
 
UTS and SeerPharma - partners in Good Manufacturing Practice (GMP) education
UTS and SeerPharma - partners in Good Manufacturing Practice (GMP) educationUTS and SeerPharma - partners in Good Manufacturing Practice (GMP) education
UTS and SeerPharma - partners in Good Manufacturing Practice (GMP) education
 
Kuantum Cro St V021
Kuantum Cro St V021Kuantum Cro St V021
Kuantum Cro St V021
 
Nordion corporate presentation_2014_q1
Nordion corporate presentation_2014_q1Nordion corporate presentation_2014_q1
Nordion corporate presentation_2014_q1
 
What are the benefits of QMS for a fertility centre and how do we measure them
What are the benefits of QMS for a fertility centre and how do we measure themWhat are the benefits of QMS for a fertility centre and how do we measure them
What are the benefits of QMS for a fertility centre and how do we measure them
 
Yasser Jasser CV 2016
Yasser Jasser CV 2016Yasser Jasser CV 2016
Yasser Jasser CV 2016
 
Activa Cro Presentacion Jan 09
Activa Cro Presentacion Jan 09Activa Cro Presentacion Jan 09
Activa Cro Presentacion Jan 09
 
CV LB v8 short 2015 Document
CV LB v8 short 2015 DocumentCV LB v8 short 2015 Document
CV LB v8 short 2015 Document
 
Nordion corporate presentation
Nordion corporate presentationNordion corporate presentation
Nordion corporate presentation
 
Joint Commission International (JCI)
Joint Commission International (JCI)Joint Commission International (JCI)
Joint Commission International (JCI)
 
IDSC Expertise Capabilities Services
IDSC Expertise Capabilities ServicesIDSC Expertise Capabilities Services
IDSC Expertise Capabilities Services
 
SHERIN KUNJAMMA RAJ
SHERIN KUNJAMMA RAJSHERIN KUNJAMMA RAJ
SHERIN KUNJAMMA RAJ
 

Viewers also liked

Photos - Training of Trainers (ToT) Course in Kuala Lumpur, Malaysia January ...
Photos - Training of Trainers (ToT) Course in Kuala Lumpur, Malaysia January ...Photos - Training of Trainers (ToT) Course in Kuala Lumpur, Malaysia January ...
Photos - Training of Trainers (ToT) Course in Kuala Lumpur, Malaysia January ...renee_tsea
 
Business english competition
Business english competitionBusiness english competition
Business english competitionskillsforlife
 
Case Study Analysis Of Google
Case Study Analysis Of GoogleCase Study Analysis Of Google
Case Study Analysis Of Googleabnguyen28
 
3 Things Every Sales Team Needs to Be Thinking About in 2017
3 Things Every Sales Team Needs to Be Thinking About in 20173 Things Every Sales Team Needs to Be Thinking About in 2017
3 Things Every Sales Team Needs to Be Thinking About in 2017Drift
 

Viewers also liked (7)

Photos - Training of Trainers (ToT) Course in Kuala Lumpur, Malaysia January ...
Photos - Training of Trainers (ToT) Course in Kuala Lumpur, Malaysia January ...Photos - Training of Trainers (ToT) Course in Kuala Lumpur, Malaysia January ...
Photos - Training of Trainers (ToT) Course in Kuala Lumpur, Malaysia January ...
 
Business english competition
Business english competitionBusiness english competition
Business english competition
 
Useful ideas for the class
Useful ideas for the classUseful ideas for the class
Useful ideas for the class
 
1st TOT workshop by DR.Mohamed Ayman
1st TOT workshop by DR.Mohamed Ayman1st TOT workshop by DR.Mohamed Ayman
1st TOT workshop by DR.Mohamed Ayman
 
How We Caffeinate
How We CaffeinateHow We Caffeinate
How We Caffeinate
 
Case Study Analysis Of Google
Case Study Analysis Of GoogleCase Study Analysis Of Google
Case Study Analysis Of Google
 
3 Things Every Sales Team Needs to Be Thinking About in 2017
3 Things Every Sales Team Needs to Be Thinking About in 20173 Things Every Sales Team Needs to Be Thinking About in 2017
3 Things Every Sales Team Needs to Be Thinking About in 2017
 

Similar to Case Study: Dementia

ClinActis Webinar: Tackling Dementia & Alzheimer's in Asia Pacific
ClinActis Webinar: Tackling Dementia & Alzheimer's in Asia PacificClinActis Webinar: Tackling Dementia & Alzheimer's in Asia Pacific
ClinActis Webinar: Tackling Dementia & Alzheimer's in Asia PacificClinActis Pte Ltd
 
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)MS Trust
 
ClinActis Paediatric Trials in Asia
ClinActis Paediatric Trials in AsiaClinActis Paediatric Trials in Asia
ClinActis Paediatric Trials in AsiaClinActis Pte Ltd
 
Statement of Capability June 2015
Statement of Capability June 2015Statement of Capability June 2015
Statement of Capability June 2015Ryan Cowan
 
Telemedicine Lessons from Walmart & Texas Prisons - Dr. Glenn Hammack 9 feb2017
Telemedicine Lessons from Walmart & Texas Prisons - Dr. Glenn Hammack 9 feb2017Telemedicine Lessons from Walmart & Texas Prisons - Dr. Glenn Hammack 9 feb2017
Telemedicine Lessons from Walmart & Texas Prisons - Dr. Glenn Hammack 9 feb2017VSee
 
Stephanice Starek Vet Tech
Stephanice Starek Vet TechStephanice Starek Vet Tech
Stephanice Starek Vet TechStephanie Starek
 
MEDICAL OFFICERS IN SINGAPORE - POSITIONS OPEN
MEDICAL OFFICERS IN SINGAPORE - POSITIONS OPENMEDICAL OFFICERS IN SINGAPORE - POSITIONS OPEN
MEDICAL OFFICERS IN SINGAPORE - POSITIONS OPENWendy Tan
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)NHSNWRD
 
Care Diagnostic Centre
Care Diagnostic CentreCare Diagnostic Centre
Care Diagnostic CentreCarediagnostic
 
Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014healthtechqld
 
PPPI - the involvement of patients or people in the design and development o...
PPPI -  the involvement of patients or people in the design and development o...PPPI -  the involvement of patients or people in the design and development o...
PPPI - the involvement of patients or people in the design and development o...ipposi
 
National Skin Centre Dermatology Research Newsletter
National Skin Centre Dermatology Research NewsletterNational Skin Centre Dermatology Research Newsletter
National Skin Centre Dermatology Research NewsletterJ W
 
North West General Hospital and Research Center
North West General Hospital and Research CenterNorth West General Hospital and Research Center
North West General Hospital and Research CenterOsama Yousaf
 
Surepath labs company profile
Surepath labs company profileSurepath labs company profile
Surepath labs company profileHimanshu Sachdeva
 
CURRICULUM VITAE 2015
CURRICULUM VITAE 2015CURRICULUM VITAE 2015
CURRICULUM VITAE 2015Jaco Greyling
 

Similar to Case Study: Dementia (20)

ClinActis Webinar: Tackling Dementia & Alzheimer's in Asia Pacific
ClinActis Webinar: Tackling Dementia & Alzheimer's in Asia PacificClinActis Webinar: Tackling Dementia & Alzheimer's in Asia Pacific
ClinActis Webinar: Tackling Dementia & Alzheimer's in Asia Pacific
 
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
 
ClinActis Paediatric Trials in Asia
ClinActis Paediatric Trials in AsiaClinActis Paediatric Trials in Asia
ClinActis Paediatric Trials in Asia
 
Statement of Capability June 2015
Statement of Capability June 2015Statement of Capability June 2015
Statement of Capability June 2015
 
Telemedicine Lessons from Walmart & Texas Prisons - Dr. Glenn Hammack 9 feb2017
Telemedicine Lessons from Walmart & Texas Prisons - Dr. Glenn Hammack 9 feb2017Telemedicine Lessons from Walmart & Texas Prisons - Dr. Glenn Hammack 9 feb2017
Telemedicine Lessons from Walmart & Texas Prisons - Dr. Glenn Hammack 9 feb2017
 
India's most trusted dignostics and pathalogy centres
India's most trusted dignostics and pathalogy centresIndia's most trusted dignostics and pathalogy centres
India's most trusted dignostics and pathalogy centres
 
Ubiqare group9
Ubiqare group9Ubiqare group9
Ubiqare group9
 
Stephanice Starek Vet Tech
Stephanice Starek Vet TechStephanice Starek Vet Tech
Stephanice Starek Vet Tech
 
MEDICAL OFFICERS IN SINGAPORE - POSITIONS OPEN
MEDICAL OFFICERS IN SINGAPORE - POSITIONS OPENMEDICAL OFFICERS IN SINGAPORE - POSITIONS OPEN
MEDICAL OFFICERS IN SINGAPORE - POSITIONS OPEN
 
Latest binder
Latest binderLatest binder
Latest binder
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
 
NIHR partnering with industry
NIHR partnering with industryNIHR partnering with industry
NIHR partnering with industry
 
Care Diagnostic Centre
Care Diagnostic CentreCare Diagnostic Centre
Care Diagnostic Centre
 
Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014
 
PPPI - the involvement of patients or people in the design and development o...
PPPI -  the involvement of patients or people in the design and development o...PPPI -  the involvement of patients or people in the design and development o...
PPPI - the involvement of patients or people in the design and development o...
 
National Skin Centre Dermatology Research Newsletter
National Skin Centre Dermatology Research NewsletterNational Skin Centre Dermatology Research Newsletter
National Skin Centre Dermatology Research Newsletter
 
CRC SGH Newsletter Issue 52
CRC SGH Newsletter Issue 52CRC SGH Newsletter Issue 52
CRC SGH Newsletter Issue 52
 
North West General Hospital and Research Center
North West General Hospital and Research CenterNorth West General Hospital and Research Center
North West General Hospital and Research Center
 
Surepath labs company profile
Surepath labs company profileSurepath labs company profile
Surepath labs company profile
 
CURRICULUM VITAE 2015
CURRICULUM VITAE 2015CURRICULUM VITAE 2015
CURRICULUM VITAE 2015
 

Recently uploaded

Psychedelic Treatment Planning: Opportunities in Integrated Care
Psychedelic Treatment Planning: Opportunities in Integrated CarePsychedelic Treatment Planning: Opportunities in Integrated Care
Psychedelic Treatment Planning: Opportunities in Integrated CareBrian Peacock
 
Biochemistry of Carbohydrates for MBBS, BDS, Lab Med 2024.pptx
Biochemistry of Carbohydrates for MBBS, BDS, Lab Med 2024.pptxBiochemistry of Carbohydrates for MBBS, BDS, Lab Med 2024.pptx
Biochemistry of Carbohydrates for MBBS, BDS, Lab Med 2024.pptxRajendra Dev Bhatt
 
Tuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
Tuberculosis .pptx Department of Physiotherapy, SHUATS, PrayagrajTuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
Tuberculosis .pptx Department of Physiotherapy, SHUATS, PrayagrajSurabhi Srivastava
 
Scanning electron microscope - SEM , Its applicability in rasashastra
Scanning electron microscope - SEM , Its applicability in rasashastraScanning electron microscope - SEM , Its applicability in rasashastra
Scanning electron microscope - SEM , Its applicability in rasashastraDr. Madduru Muni Haritha
 
Autism and Savant Syndrome|Study|The Good doctor .pptx
Autism and Savant Syndrome|Study|The Good doctor .pptxAutism and Savant Syndrome|Study|The Good doctor .pptx
Autism and Savant Syndrome|Study|The Good doctor .pptxScripted Symptoms
 
Best neurologist in jalandhar Punjab India
Best neurologist in jalandhar Punjab IndiaBest neurologist in jalandhar Punjab India
Best neurologist in jalandhar Punjab IndiaNHS Hospital
 
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdfSEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdfmarlonduqueupb
 
Anesthesia Implications in cannabis Users.pptx
Anesthesia Implications in cannabis Users.pptxAnesthesia Implications in cannabis Users.pptx
Anesthesia Implications in cannabis Users.pptxhrowshan
 
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...Abhinav S
 
Introducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessIntroducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessFredrick Amos
 
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...Subrata Roy
 
Poliomyelitis.pptx Department of Physiotherapy, SHUATS, Prayagraj
Poliomyelitis.pptx Department of Physiotherapy, SHUATS, PrayagrajPoliomyelitis.pptx Department of Physiotherapy, SHUATS, Prayagraj
Poliomyelitis.pptx Department of Physiotherapy, SHUATS, PrayagrajSurabhi Srivastava
 
SCIENTIFIC APPROACH OF DIET IN MASANUMASIKA GARBINI PARICHARYA – FOR A HEALTH...
SCIENTIFIC APPROACH OF DIET IN MASANUMASIKA GARBINI PARICHARYA – FOR A HEALTH...SCIENTIFIC APPROACH OF DIET IN MASANUMASIKA GARBINI PARICHARYA – FOR A HEALTH...
SCIENTIFIC APPROACH OF DIET IN MASANUMASIKA GARBINI PARICHARYA – FOR A HEALTH...Dr. Madduru Muni Haritha
 
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxGLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxWINCY THIRUMURUGAN
 
Typhoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
Typhoid.pptx Department of Physiotherapy, SHUATS, PrayagrajTyphoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
Typhoid.pptx Department of Physiotherapy, SHUATS, PrayagrajSurabhi Srivastava
 
Malaria Disease.pptx Department of Physiotherapy, SHUATS, Prayagraj
Malaria Disease.pptx Department of Physiotherapy, SHUATS, PrayagrajMalaria Disease.pptx Department of Physiotherapy, SHUATS, Prayagraj
Malaria Disease.pptx Department of Physiotherapy, SHUATS, PrayagrajSurabhi Srivastava
 
KOSHTA CONCEPT IN AYURVEDA BY VIJAY R K
KOSHTA CONCEPT IN AYURVEDA  BY  VIJAY R KKOSHTA CONCEPT IN AYURVEDA  BY  VIJAY R K
KOSHTA CONCEPT IN AYURVEDA BY VIJAY R Kvinaykumarrkumabar
 
USG,CT AND MR IMAGING OF HEPATIC MASS LESIONS.
USG,CT AND MR IMAGING OF HEPATIC MASS LESIONS.USG,CT AND MR IMAGING OF HEPATIC MASS LESIONS.
USG,CT AND MR IMAGING OF HEPATIC MASS LESIONS.vrchk912
 
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesCHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesMohamed AbdElhady
 
Population of India and Family welfare programme.pptx
Population of India and Family welfare programme.pptxPopulation of India and Family welfare programme.pptx
Population of India and Family welfare programme.pptxDr. Dheeraj Kumar
 

Recently uploaded (20)

Psychedelic Treatment Planning: Opportunities in Integrated Care
Psychedelic Treatment Planning: Opportunities in Integrated CarePsychedelic Treatment Planning: Opportunities in Integrated Care
Psychedelic Treatment Planning: Opportunities in Integrated Care
 
Biochemistry of Carbohydrates for MBBS, BDS, Lab Med 2024.pptx
Biochemistry of Carbohydrates for MBBS, BDS, Lab Med 2024.pptxBiochemistry of Carbohydrates for MBBS, BDS, Lab Med 2024.pptx
Biochemistry of Carbohydrates for MBBS, BDS, Lab Med 2024.pptx
 
Tuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
Tuberculosis .pptx Department of Physiotherapy, SHUATS, PrayagrajTuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
Tuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
 
Scanning electron microscope - SEM , Its applicability in rasashastra
Scanning electron microscope - SEM , Its applicability in rasashastraScanning electron microscope - SEM , Its applicability in rasashastra
Scanning electron microscope - SEM , Its applicability in rasashastra
 
Autism and Savant Syndrome|Study|The Good doctor .pptx
Autism and Savant Syndrome|Study|The Good doctor .pptxAutism and Savant Syndrome|Study|The Good doctor .pptx
Autism and Savant Syndrome|Study|The Good doctor .pptx
 
Best neurologist in jalandhar Punjab India
Best neurologist in jalandhar Punjab IndiaBest neurologist in jalandhar Punjab India
Best neurologist in jalandhar Punjab India
 
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdfSEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
 
Anesthesia Implications in cannabis Users.pptx
Anesthesia Implications in cannabis Users.pptxAnesthesia Implications in cannabis Users.pptx
Anesthesia Implications in cannabis Users.pptx
 
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
 
Introducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessIntroducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitness
 
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
 
Poliomyelitis.pptx Department of Physiotherapy, SHUATS, Prayagraj
Poliomyelitis.pptx Department of Physiotherapy, SHUATS, PrayagrajPoliomyelitis.pptx Department of Physiotherapy, SHUATS, Prayagraj
Poliomyelitis.pptx Department of Physiotherapy, SHUATS, Prayagraj
 
SCIENTIFIC APPROACH OF DIET IN MASANUMASIKA GARBINI PARICHARYA – FOR A HEALTH...
SCIENTIFIC APPROACH OF DIET IN MASANUMASIKA GARBINI PARICHARYA – FOR A HEALTH...SCIENTIFIC APPROACH OF DIET IN MASANUMASIKA GARBINI PARICHARYA – FOR A HEALTH...
SCIENTIFIC APPROACH OF DIET IN MASANUMASIKA GARBINI PARICHARYA – FOR A HEALTH...
 
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxGLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
 
Typhoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
Typhoid.pptx Department of Physiotherapy, SHUATS, PrayagrajTyphoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
Typhoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
 
Malaria Disease.pptx Department of Physiotherapy, SHUATS, Prayagraj
Malaria Disease.pptx Department of Physiotherapy, SHUATS, PrayagrajMalaria Disease.pptx Department of Physiotherapy, SHUATS, Prayagraj
Malaria Disease.pptx Department of Physiotherapy, SHUATS, Prayagraj
 
KOSHTA CONCEPT IN AYURVEDA BY VIJAY R K
KOSHTA CONCEPT IN AYURVEDA  BY  VIJAY R KKOSHTA CONCEPT IN AYURVEDA  BY  VIJAY R K
KOSHTA CONCEPT IN AYURVEDA BY VIJAY R K
 
USG,CT AND MR IMAGING OF HEPATIC MASS LESIONS.
USG,CT AND MR IMAGING OF HEPATIC MASS LESIONS.USG,CT AND MR IMAGING OF HEPATIC MASS LESIONS.
USG,CT AND MR IMAGING OF HEPATIC MASS LESIONS.
 
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesCHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
 
Population of India and Family welfare programme.pptx
Population of India and Family welfare programme.pptxPopulation of India and Family welfare programme.pptx
Population of India and Family welfare programme.pptx
 

Case Study: Dementia

  • 1. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Case Study: Dementia CNS
  • 2. ClinActis is exclusively focused on Asia Pacific, with solid expertise in applying international quality standards to regional specificities. ClinActis is flexible in our approach to work scope and budgeting and contracting process. Delivering Quality to Our Clients ClinActis is committed to implementing international standards in clinical trials. Our ability to deliver high quality results to our clients is based on recruiting and maintaining the best talent within our organization. ClinActis’ senior management is fully accountable for the quality of deliverables to our clients. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Your Proactive Clinical Research Partner in Asia Pacific     ClinActis Pte Ltd is a full service CRO providing clinical trial services to the pharmaceutical, medical device, medical nutrition and biotech companies in Asia Pacific. Established in 2009, ClinActis Pte Ltd is headquartered in Singapore. ClinActis Value Proposition ClinActis is a multicultural company. As such, the team is able to communicate effectively with international clients.
  • 3. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Mission and Vision     With headquarters based in Asia, all corporate decisions are made within the region, in order to better anticipate our client needs and adapt to local specificities. Vision Our vision is to become the reference CRO specialized in conducting clinical research in Asia Pacific, offering state of the art quality services, with cost effective solutions. We strive to employ people with genuine expertise in the region and with a passion for excellence, to work with our clients in the most pro-active way, and to build a relationship based on trust, transparency and strong ethics. Mission Our mission is to provide our clients with unique and dynamic expertise in applying global drug development standards to the specificities of each country in the Asia Pacific region.
  • 4. Christophe Tournerie, MD – Owner and CEO Dr. Tournerie has more than 20 years experience in clinical research in Europe and Asia Pacific including Japan, working with biotechnology companies, pharmaceutical companies and clinical research organizations. After completion of his medical studies in Paris and various hospital assignments in France, Dr. Tournerie spent a period of 3 years at the National Medical Research Institute in France in the field of drug development in anti-HIV products. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com About Our Founder His introduction to the pharmaceutical industry was as Medical Director in an American biotechnology company developing anti-HIV products. Then, he moved to a large global CRO, heading the Project management Department for South Europe, and then as Head of Operations in the Japan affiliate. Later, Dr. Tournerie headed the Asian clinical research activity for a multi-national Pharmaceutical Company, based in Singapore. More recently, Dr. Tournerie was Vice President Asia Pacific for a large global CRO, based in Singapore. During this assignment, Dr. Tournerie developed the business strategy for the region, successfully established and directed operations in 12 countries and built a highly professional team.
  • 5. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Operational Expertise – Regional Footprint ClinActis Experience §  33 years experience in clinical research in pharmaceutical and biotechnology companies as well as CROs §  27 years experience in Asia Pacific, including Australia/New Zealand, China, Malaysia, Hong Kong, India, Indonesia, the Philippines, Singapore, South Korea, Taiwan, Thailand, Japan and Vietnam §  Extensive knowledge of regulatory frameworks, best KOLs and sites across the region §  Vast therapeutic experience including Oncology, Infectious diseases, CNS, Cardiovascular, Endocrinology, and Respiratory
  • 6. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Alzheimer’s Disease Clinical Trial Considerations in Asia Pacific §  The total population of the Asia Pacific region in 2015 was estimated from United Nations data at 4.4 billion. The population aged 60 years and above was estimated at 12% in 2015. §  The dementias are a group of diseases characterised by loss of short-term memory, other thinking (cognitive) abilities and daily functioning. §  Alzheimer’s disease and vascular dementia are the most common types of dementia. §  The number of those with dementia was forecasted to increase in the Asia Pacific region from 13.7 million people in 2005 to 64.6 million by 2050.
  • 7. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com PREVALENCE AND INCIDENCE, ASIA PACIFIC 2005 2020 2050 ‘000 people Prevalence ce Incidence Prevalence Incidence Prevalence Incidence Australia 195.4 60.2 301.3 91.1 664.1 199.7 China (inc Macao) 5,541.2 1,721.0 9,596.3 2,916.7 27,004.4 8,269.0 Hong Kong SAR 59.7 18.5 109.2 32.6 332.0 99.6 India 3,248.5 1,026.8 5,541.8 1,714.4 16,290.1 4,974.6 Indonesia 606.1 191.4 1,016.8 314.1 3,042.0 932.0 Japan 1,871.2 570.2 3,251.3 983.4 4,873.1 1,417.7 Malaysia 63.0 20.1 126.8 39.0 453.9 138.8 New Zealand 38.2 11.8 54.6 16.6 117.6 35.5 Pakistan 330.1 107.3 566.6 179.3 1,916.2 584.3 Philippines 169.8 54.8 316.3 99.2 1,158.9 353.9 Singapore 22.0 6.8 52.6 15.7 186.9 56.7 South Korea 246.3 75.5 542.2 164.3 1,569.9 475.4 Taiwan 138.0 43.1 253.4 76.6 659.3 199.4 Thailand 229.1 71.4 450.2 137.2 1,233.2 377.0 Total region 13,703.6 4,282.1 23,727.1 7,262.3 64,641.5 19,687.3  
  • 8. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Singapore §  Prevalence of dementia and cognitive disorders to increase rapidly over the coming years. Fast ageing population with 15-20% of the total population above the age of 65 by year 2030. §  At the present time about 25,000 patients have dementia and this number is set to increase to 53,000 by 2020 and by 2050 the projected figure will further increase to 187,000. §  The Ministry of Health provides clinical guidelines for Alzheimer's, and support care funding through the Care Liaison service, a central body established to coordinate and facilitate the placement of elderly sick to step-down services (nursing homes & chronic sick facilities). §  In the later stages of Alzheimer’s disease, the patient may not be aware of the consequences of the illness and it would then be a family decision to get him/her assessed and investigated. Treatment would mostly be based on the symptoms observed and arrangements have to be made for the long-term care of the individual by way of providing for care-givers, especially if there are none in the family.
  • 9. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Singapore (Continued) §  In their clinical guidelines, health authorities in Singapore recommend two groups of drugs: one (Cholinesterase inhibitors) to help improve the ability to think, understand, and remember; another group of drugs is also sometimes used in Alzheimer's disease to help with behavioral problems associated with Alzheimer's disease, such as aggressiveness, agitation, depression, and anxiety. §  Potential clinical sites in Singapore are: 1. Singapore General Hospital Geriatric Medicine Department, Memory Clinic 2. Tan Tock Sing Hospital Geriatric Medicine Department 3. Changi General Hospital Geriatric Medicine Department 4. National University Hospital Neurology department
  • 10. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Taiwan §  According to available data, 10.63% of the population in Taiwan is older adults, and 4.8% of older adults have dementia. §  Around 110,000 Taiwanese suffer from Alzheimer's disease and other degenerative disorders, according to a survey released by the Taiwan Alzheimer's Disease Association. Alzheimer's disease causes 60-70% of all cases of dementia. §  The healthcare system is well organized to take care of Alzheimer’s patients, either in hospitals, where patients are treated in outpatient and inpatient service from neurobiology and psychiatry departments, or in nursing homes, or in long-term care facilities. §  The standard therapy available in Taiwan includes medications covered by health insurance if the patient meets the criteria: • Acetylcholinesteraseinhibitor, AChEI: Aricept, donepezil, Exelon,rivastigmine, Reminyl, galantamine • NMDA receptor antagonist: Ebixa, memantine, Witgen,memantine • Antipsychotics • Antidepressants •  Cognitive therapy, reminiscence therapy, music therapy and art therapy.
  • 11. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Taiwan (Continued) §  There are 4 leading neurologists in the field of Alzheimer's disease in Taipei, Taiwan. They have good patient population at their site and they have experience in several clinical trials. 1. Dr. Jong-Ling Fuh / Taipei Veterans General Hospital 2. Dr. Chin-Chang Huang / Chang-Gung Medical Foundation - Linkou branch 3. Dr. Yu-Wan Yang / China Medical University Hospital 4. Dr. Chiung-Chih / Chang Chang Gung Memorial Hospital, Kaohsiang §  We can safely assume that there are other sites based outside Taipei that can also be involved and offer a solid patient potential.
  • 12. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Korea §  Up to 10% of the elderly in Korea suffer from dementia. Further, prevalence estimates of Alzheimer's disease range from 4.2% to 9.0%. Annual incidence rates for Alzheimer's are 2.7% to 3.4%. Thus major mental disorders are already prevalent among the Korean elderly and are likely to increase rapidly. §  The healthcare system is well organized to take care of Alzheimer’s patients: Primary Care: Private Clinic Most potential patients visit private clinics. If they are suspected to be diagnosed with dementia, the clinic’s doctor refers patients to either general hospitals (3rd healthcare hospital defined by government medical law) or middle hospitals (2nd healthcare hospital defined by government). Public Health Centers 25 Dementia Centers are operating as Dementia Program in Seoul City. Preventing program & education and dementia health exams are conducted in these centers. Dementia Patients are registered into the Dementia Registry database managed by Seoul City. Dedicated doctors are working in the centers. Other provinces are in charge of public Health Centers. General Hospital If dementia medication or cognitive activities are necessary for the patients, they are referred to the General Hospital. The following have a specific Center of dementia or Parkinson Disease in Seoul: Samsung Medical Center, Asan Medical Center, Severance Hospital, Seoul National University. Other provinces have a specific center in National University Hospital.
  • 13. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Korea (Continued) §  The standard therapy in Korea includes the following medication, which should be taken by patients within 2 years after diagnosis: • Antioxidant, NSAID, Hormone Therapy e.g. estrogen, NMDA antagonist + ChEI or memantine • For Mild – plus cognitive disorder Tacrine or Donepezil(Aricept Tab) is given to the patient. • For Mild to Moderate: Tacrine, Donepezil, Rivastigmine (Patch or Oral), Galantamine • BPSD’s sign: antidepressants, antipsychotic drug, Mood Stabilizer is given to the patient. §  The standard therapy should also include a change of lifestyle and environment, cognitive activities & training, and behavior training. §  Patients are also provided with a health caregiver or may use hospitalized facilities.
  • 14. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com ClinActis CNS and ADExperience Indication   Study Title (Blinded)   Study Phase   No. of sites   No. of patients   Location (Countries)   Responsibilities   Client (Blinded)   Alzheimer’s Disease   A multicenter, double-blind, placebo- controlled, randomised, parallel-group phase 3 study to evaluate the safety and efficacy of XXX in patients with mild to moderate Alzheimer’s disease   III   25   202   KR, TW, SG, MY, PH, HK, TH   PM, Reg, Monitoring   EU Pharma   Dementia   A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of XXX in Subjects with Behavioral Variant Frontotemporal Dementia   III   4   24   SG, AU   Pre-study visit   Asia Biotech   Progressive Supranuclear Palsy   A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel groups, phase 2b/3 study to compare the efficacy and safety of XXX versus placebo in the treatment of patients suffering from Progressive Supranuclear Palsy (PSP)   III   20   30   SG, HK, KR, TW, PH, MY, TH   PM, Reg, Monitoring   EU Pharma   Multiple Sclerosis   A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel groups, phase 2/3 study to compare the efficacy and safety of XXX in combination with riluzole versus placebo in combination with riluzole in the treatment of patients suffering from Amyotrophic Lateral Sclerosis (ALS)   III   30   80   SG, HK, KR, TW, PH, MY, TH   PM, Reg, Monitoring   EU Pharma  
  • 15. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com CNS and ADExperience (Continued) Indication   Study Title (Blinded)   Study Phase   No. of sites   No. of patients   Location (Countries)   Responsibilities   Client (Blinded)   Brain Injury   A randomized, double-blind, placebo- controlled trial to investigate safety and efficacy of XXX in patients with traumatic brain injury.   III/ IV   12   216   AU, SG, HK, PH   PM, Reg, Monitoring   EU Pharma   Multiple Sclerosis   Single-centre randomized crossover open-label study of pharmacokinetics, pharmacodynamics and safety of XXX and Rebif® (Merck Serono S.p.А., Italy) after single subcutaneous administration to healthy volunteers   I   1   18   SG   PM, Reg, Monitoring   EU Biotech   Multiple Sclerosis   Single-centre randomized crossover open-label study of pharmacokinetics, pharmacodynamics and safety of XXX and Avonex® (Biogen Idec. Ltd., United Kingdom) after single intramuscular administration to healthy volunteers   I   1   18   SG   PM, Reg, Monitoring   EU Biotech  
  • 16. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Process in Asia Pacific when diagnosis with Dementia occurs §  Patient will be referred by GP to specialist for further evaluation of the condition. §  This management is mainly applicable to developed countries (like Australia, Singapore, Korea, Taiwan, Hong Kong, Malaysia) where the: -  People are more educated and can understand etiology of dementia and would seek treatment from medical practitioner -  People can afford the treatment in their own country with better healthcare coverage §  For developing countries, like Indonesia, Thailand, Philippines, referral to GP might not be applicable because: -  People will think this is part of the ageing process and ignore the importance to seek treatment.
  • 17. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Countries to consider for Clinical Trials in AD in Asia Pacific   §  Australia, Singapore, Taiwan, Korea, Hong Kong & Malaysia. There is currently no proven cure for MCi and dementia, hence patients and doctors are very willing to participate in drug trials.
  • 18. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Site Capabilities in Asia Pacific   §  We can use highly skilled and experienced sites; PI and site staffs who are currently taking part in our on-going Alzheimer study in the region. The PIs and team are well trained professionals for cognitive assessment. The team in our on-going study has no issue to perform this assessment. §  For raters, it is also important to consider standardized training – eg: online training to ensure consistency in the assessments. Also, refresher trainings (eg: every 6 months) helps ensure raters remain updated on the trial. §  If MRI/CT scans are required, it is best to have centralized readers. Our sites are familiar with online portal to upload scans for centralized reviewer.
  • 19. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Benefits of conducting AD study in Asia Pacific   §  We have good patient pools in the region, e.g. Singapore pre-screened ~800 and Hong Kong pre-screened ~1000 of patients with suspected mental disorder/dysfunction in their clinic setting within 3-6 months. §  Less costly than US/European countries §  Trained and experienced site personnel and CRO team
  • 20. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Potential pitfalls and ClinActis measures to overcome them   §  The challenge in taking consent involving family members. To overcome this, we train our site personnel on how to explain the study and keep them updated of the study status. For example, we provide newsletters and email blasts to update site personnel of the recruitment status and safety data. Also, we put up educational posters of dementia condition at the sites. These efforts help to reassure subjects and their family members. §  Care-giver support is needed. Our current trial requires weekly blood taking. To minimize inconvenience to the caregiver, some of the sites have study nurses to visit the subjects’ homes for blood taking. §  Patient inconvenience to attend too many hospital visits as the majority of them are elderly.
  • 21. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Potential pitfalls and ClinActis measures to overcome them (Continued)   §  Emotional swing in elderly person that affect the assessment of cognitive test. It is important to give subjects and their family members a sense of familiarity. Hence, sites we selected have low staff turnover and dedicated facilities. This is helpful in subject retention. §  Patients are reluctant to draw blood too frequently, which limits the recruitment in AD studies.
  • 22. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com ClinActis success stories in Alzheimer’s Disease   §  For the current Alzheimer’s study, recruitment is challenging because subjects are required to be above 50kg and do weekly blood taking. Nonetheless, we managed to recruit patients because of the following strategies: §  Meeting / Calls with PI and site staff before SIV to train the team on eligibility criteria – this is to ensure that the site screens their database for eligible subjects prior to SIV. This strategy also helped us to have fast FPI. §  Motivational visits §  Newsletters. §  Sharing of best practices among sites. Once the site recruits a patient, we would call them to find out how they recruited the patients and share their success methodology with other sites.
  • 23. ClinActis Pte Ltd - 112 Robinson Road - #06-04 - Singapore 068902 Telephone: +65 6436 5500 - info@clinactis.com Contact Us for More Information     Imen Jelassi, PharmD, MSc EU Director, Strategic Relations M: +33 6 28 11 13 71 E: ijelassi@clinactis.com Bill Van Nostrand Head of Business Development, North America M: +1 908-229-5220 E: bvannostrand@clinactis.com